100 Participants NeededMy employer runs this trial

Radon App for Lung Cancer Prevention

Recruiting at 1 trial location
SK
Overseen BySoojung Kim Interim Dean, School of Graduate Studies, PhD, MPH
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of North Dakota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new app designed to prevent lung cancer by encouraging radon testing. Radon, a gas that can cause lung cancer, poses a particular risk to children. The app, called the radon app, provides educational content to mothers of young children, promoting testing when they receive a free radon test kit. Mothers with children aged 4 or younger who have smartphones might find this trial suitable. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative lung cancer prevention strategies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the radon app is safe for use?

In this study, participants will use a new app designed to encourage radon testing. As a digital tool, it does not involve medication or medical procedures, eliminating typical safety concerns like side effects. The app provides information about radon, a gas that can increase lung cancer risk. The goal is to motivate people to test for radon at home and reduce their exposure. No reports of problems have emerged from using the app itself, so participants can expect it to be safe and easy to use.12345

Why are researchers excited about this trial?

Unlike traditional lung cancer prevention efforts that often rely on policy changes or environmental regulations, the radon app offers a novel, tech-savvy approach. This app aims to educate users directly through mobile-friendly content adapted from EPA brochures, making crucial information about radon exposure easily accessible and engaging. Researchers are excited about this trial because it leverages digital technology to empower individuals with knowledge, potentially leading to more proactive and informed decisions about their lung health.

What evidence suggests that the radon app is effective for lung cancer prevention?

Studies have shown that radon exposure is a major risk factor for lung cancer. It ranks as the second leading cause of lung cancer overall and the leading cause among non-smokers. Research indicates that radon links to 3-20% of global lung cancer deaths, with about 21,000 cases per year in the U.S. alone. Testing for radon offers an affordable way to reduce this risk. In this trial, participants will use the radon app, which encourages testing by providing educational content about radon and its dangers. This approach could help lower lung cancer cases by promoting awareness and preventive action.24678

Are You a Good Fit for This Trial?

This trial is for mothers who have children aged 4 or younger. Participants should be willing to use a mobile app and receive a free radon test kit to check their home for radon exposure.

Inclusion Criteria

Participants own a smartphone
Children brought in for appointments are their biological or adoptive child
I am a mother of a child who is 4 years old or younger.

Exclusion Criteria

Previous testing for radon within the past two (2) years
My child is older than 4 years.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline

Participants complete a pre-exposure survey and receive a free radon test kit

Initial enrollment
1 visit (in-person or virtual)

App Engagement

Participants use the radon app for educational content and reminders for 4 months

4 months

Follow-up

Participants complete a post-exposure survey and return radon test kits for analysis

2 months
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • The radon app

Trial Overview

The study is testing whether using a special smartphone app can encourage mothers of young children to test their homes for radon by providing them with information and a free test kit.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: The radon appExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Dakota

Lead Sponsor

Trials
17
Recruited
1,200+

National Institute of General Medical Sciences (NIGMS)

Collaborator

Trials
315
Recruited
251,000+

Citations

Radon and Lung Cancer: Current Trends and Future ... - PMC

Radon represents the main risk factor of lung cancer in non-smokers and the second one in smoking patients.

Radon and lung cancer: Current status and future prospects

It is estimated that 3–20 % of global lung cancer deaths can be attributed to radon exposure, and this percentage reaches 30 % in never smokers (Torres-Duran, ...

Radon Control Activities for Lung Cancer Prevention in ...

Exposure to radon is the second leading risk factor, causing approximately 21,000 cases of lung cancer per year (2–8). Analyses of pooled data ...

Lung cancer deaths from indoor radon and the cost ...

We conclude that basic preventive measures against radon in new homes is likely to be a highly cost effective public health intervention measure.

Analysis of Benefits and Costs of Radon Reduction ...

both smoking and radon is likely to be a highly cost-effective way to prevent lung cancer. Page 6. 1. Introduction. Radon has long been ...

6 Myths About Radon and Lung Cancer

The Environmental Protection Agency (EPA) classifies radon as a carcinogen because it can get into the air and increase the risk of lung cancer.

Health Risk of Radon

Radon is the number one cause of lung cancer among non-smokers, according to EPA estimates. Overall, radon is the second leading cause of lung cancer.

Medical surveillance of workers exposed to radon

The health surveillance of workers exposed to Radon is aimed at the prevention and early diagnosis of lung cancer.